Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2026)

Maravai Lifesciences Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 139.06% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was -$55.7 million, a 1084.61% decrease from a year earlier, with the FY2025 full-year figure at -$70.7 million, down 1558.49% from the prior year.
• Free Cash Flow advanced to $4.2 million in Q1 2026 per MRVI's latest filing, from -$35.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $161.6 million in Q2 2022 and bottomed at -$35.0 million in Q4 2025.
• The 5-year median for Free Cash Flow is $4.5 million (2024), against an average of $35.1 million.
• Across the five-year window, Free Cash Flow surged 373.63% in 2024 and plunged 633.96% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at $108.5 million in 2022, then plunged by 49.74% to $54.5 million in 2023, then tumbled by 87.98% to $6.6 million in 2024, then plunged by 633.96% to -$35.0 million in 2025, then surged by 112.08% to $4.2 million in 2026.
• Per Business Quant, the three latest MRVI Free Cash Flow figures stand at $4.2 million (Q1 2026), -$35.0 million (Q4 2025), and -$8.0 million (Q3 2025).